(Q37519014)

English

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy

scientific article published on 04 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

0 references

1 reference

based on heuristic

inferred from title

4

object named as

Peter Selby

0 references

6

object named as

Alan Melcher

0 references

author name string

Alison Merrick

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Rosa Maria Diaz

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dearbhaile O'Donnell

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Richard Vile

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

4 December 2007

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

57

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

897-906

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Natural killer and dendritic cell liaison: recent insights and open questions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Different faces of regulatory DCs in homeostasis and immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Dendritic cells for the immunotherapy of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Antigen presentation and T cell stimulation by dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Danger signals: SOS to the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Natural adjuvants: endogenous activators of dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Immunotherapy of malignancy by in vivo gene transfer into tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

23 August 2017

Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

14 September 2017

Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

14 September 2017

Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

14 September 2017

Dendritic cell maturation is required for initiation of the immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

28 September 2017

Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

25 June 2018

Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

2 September 2018

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

2 September 2018

Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

2 September 2018

A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3903051

2 September 2018

Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strain-specific variations in the development of dendritic cells in murine bone-marrow cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with allogeneic dendritic cells fused to carcinoma cells induces antitumor immunity in MUC1 transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell?autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18057935

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00262-007-0426-9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37519014&oldid=2200487216"